Drug interactions in COVID-19 treatment. Systematic review

• Egile Nagusiak: Arkadiusz Adamiszak (Egilea), Tomasz Torliński (Egilea), Edmund Grześkowiak (Egilea), Alicja Bartkowska-Śniatkowska (Egilea), Agnieszka Bienert (Egilea)
• Formatua: Liburua
• Argitaratua: Polish Pharmaceutical Society, 2022-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The COVID-19 pandemic has driven the experimental, off-label treatments with co-administration of supportive therapies for many patients with severe infections and coexisting chronic conditions. This situation has inevitably led to polypharmacy, which is always related to a disproportionately large...